BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32443355)

  • 1. The effects of physical activity on physiological markers in breast cancer survivors: A meta-analysis.
    Kang XY; Xu QY; Yu Z; Han SF; Zhu YF; Lv X
    Medicine (Baltimore); 2020 May; 99(20):e20231. PubMed ID: 32443355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Exercise on Insulin, IGF Axis, Adipocytokines, and Inflammatory Markers in Breast Cancer Survivors: A Systematic Review and Meta-analysis.
    Kang DW; Lee J; Suh SH; Ligibel J; Courneya KS; Jeon JY
    Cancer Epidemiol Biomarkers Prev; 2017 Mar; 26(3):355-365. PubMed ID: 27742668
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of exercise training on fasting insulin, insulin resistance, insulin-like growth factors, and insulin-like growth factor binding proteins in postmenopausal breast cancer survivors: a randomized controlled trial.
    Fairey AS; Courneya KS; Field CJ; Bell GJ; Jones LW; Mackey JR
    Cancer Epidemiol Biomarkers Prev; 2003 Aug; 12(8):721-7. PubMed ID: 12917202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical activity and biomarkers in breast cancer survivors: a systematic review.
    Löf M; Bergström K; Weiderpass E
    Maturitas; 2012 Oct; 73(2):134-42. PubMed ID: 22840658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of raloxifene administration on serum levels of insulin-like growth factor-1 and insulin-like growth factor-binding protein 3 levels: A systematic review and meta-analysis of randomized controlled trials.
    Sun Y; Xiong Y; Meng YL; Santos HO; Athayde FL; de Souza IGO; Yang L
    Growth Horm IGF Res; 2021; 60-61():101421. PubMed ID: 34384975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IGF1 and risk of additional breast cancer in the WHEL study.
    Al-Delaimy WK; Flatt SW; Natarajan L; Laughlin GA; Rock CL; Gold EB; Caan BJ; Parker BA; Pierce JP
    Endocr Relat Cancer; 2011 Apr; 18(2):235-44. PubMed ID: 21263044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of exercise on inflammatory factors and IGF system in breast cancer survivors: a meta-analysis.
    Zhou Y; Jia N; Ding M; Yuan K
    BMC Womens Health; 2022 Dec; 22(1):507. PubMed ID: 36482346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of exercise on insulin, glucose, IGF-axis and CRP in cancer survivors: Meta-analysis and meta-regression of randomised controlled trials.
    Wang Y; Jin B; Paxton RJ; Yang W; Wang X; Jiao Y; Yu C; Chen X
    Eur J Cancer Care (Engl); 2020 Jan; 29(1):e13186. PubMed ID: 31823458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The insulin-like growth factor system is modulated by exercise in breast cancer survivors: a systematic review and meta-analysis.
    Meneses-Echávez JF; Jiménez EG; Río-Valle JS; Correa-Bautista JE; Izquierdo M; Ramírez-Vélez R
    BMC Cancer; 2016 Aug; 16(1):682. PubMed ID: 27562357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a 9-month strength training intervention on insulin, insulin-like growth factor (IGF)-I, IGF-binding protein (IGFBP)-1, and IGFBP-3 in 30-50-year-old women.
    Schmitz KH; Ahmed RL; Yee D
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1597-604. PubMed ID: 12496050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor-I and insulin are associated with the presence and advancement of adenomatous polyps.
    Schoen RE; Weissfeld JL; Kuller LH; Thaete FL; Evans RW; Hayes RB; Rosen CJ
    Gastroenterology; 2005 Aug; 129(2):464-75. PubMed ID: 16083703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized controlled trial of aerobic exercise on insulin and insulin-like growth factors in breast cancer survivors: the Yale Exercise and Survivorship study.
    Irwin ML; Varma K; Alvarez-Reeves M; Cadmus L; Wiley A; Chung GG; Dipietro L; Mayne ST; Yu H
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):306-13. PubMed ID: 19124513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of chemotherapy on medium-term physical function and activity of older breast cancer survivors, and associated biomarkers.
    Extermann M; Leeuwenburgh C; Samiian L; Sehovic M; Xu J; Cubitt C; Jacobsen PB; Pahor M; Grobmyer SR; Manini TM
    J Geriatr Oncol; 2017 Jan; 8(1):69-75. PubMed ID: 27743848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of obesity and physical activity with C-peptide, leptin, and insulin-like growth factors in breast cancer survivors.
    Irwin ML; McTiernan A; Bernstein L; Gilliland FD; Baumgartner R; Baumgartner K; Ballard-Barbash R
    Cancer Epidemiol Biomarkers Prev; 2005 Dec; 14(12):2881-8. PubMed ID: 16365005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone-binding protein is directly and IGFBP-3 is inversely associated with risk of female breast cancer.
    Pazaitou-Panayiotou K; Kelesidis T; Kelesidis I; Kaprara A; Blakeman J; Vainas I; Mpousoulegas A; Williams CJ; Mantzoros C
    Eur J Endocrinol; 2007 Feb; 156(2):187-94. PubMed ID: 17287408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of home-based strength training program on IGF-I, IGFBP-1 and IGFBP-3 in obese Latino boys participating in a 16-week randomized controlled trial.
    Kelly L; Holmberg PM; Schroeder ET; Loza A; Lin X; Moody A; Hughes A; Gibson AM; Kirk A
    J Pediatr Endocrinol Metab; 2019 Oct; 32(10):1121-1129. PubMed ID: 31539362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of droloxifene on plasma levels of insulin-like growth factor (IGF)-I, Pro-IGF-IIE, insulin-like growth factor binding protein (IGFBP)-1 and IGFBP-3 in breast cancer patients.
    Helle SI; Anker GB; Tally M; Hall K; Lønning PE
    J Steroid Biochem Mol Biol; 1996 Feb; 57(3-4):167-71. PubMed ID: 8645625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating levels of insulin-like growth factor I, its binding proteins -1,-2, -3, C-peptide and risk of postmenopausal breast cancer.
    Keinan-Boker L; Bueno De Mesquita HB; Kaaks R; Van Gils CH; Van Noord PA; Rinaldi S; Riboli E; Seidell JC; Grobbee DE; Peeters PH
    Int J Cancer; 2003 Aug; 106(1):90-5. PubMed ID: 12794762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk.
    Schernhammer ES; Holly JM; Pollak MN; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):699-704. PubMed ID: 15767352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II.
    Schernhammer ES; Holly JM; Hunter DJ; Pollak MN; Hankinson SE
    Endocr Relat Cancer; 2006 Jun; 13(2):583-92. PubMed ID: 16728584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.